Loading clinical trials...
Loading clinical trials...
A Phase 2, Multi-center, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy and Safety of OK-101 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Conditions
Interventions
OK-101
Placebo
Locations
6
United States
Eye Research Foundation
Newport Beach, California, United States
Vision Institute
Colorado Springs, Colorado, United States
Butchertown clinical Trials
Louisville, Kentucky, United States
Andover Eye Associates
Andover, Massachusetts, United States
Core Inc.
Shelby, North Carolina, United States
Total Eye Care, PA
Memphis, Tennessee, United States
Start Date
April 28, 2023
Primary Completion Date
December 15, 2023
Completion Date
December 15, 2023
Last Updated
February 9, 2024
NCT07463950
NCT07363824
NCT07396441
NCT05865379
NCT05865457
NCT06984549
Lead Sponsor
Okyo Pharma Ltd
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions